04:17 PM EST, 12/23/2025 (MT Newswires) -- Wendell Wierenga, Director, on December 22, 2025, sold 20,000 shares in Cytokinetics ( CYTK ) for $1,322,800. Following the Form 4 filing with the SEC, Wierenga has control over a total of 32,444 common shares of the company, with 32,444 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000106198325000051/xslF345X05/form4.xml